Clinical Study on the Safety of Double and a Half Layered Esophagojejunal Anastomosis in Curative Gastrectomy
NCT05282563 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21
Last updated 2022-03-16
Summary
Surgical resection remain the main means for gastric cancer. With the improvement of surgical techniques and concepts, the incidence of postoperative complications gradually decreased, but esophagojejunostomy complications occur frequently. Studies have showed that the risks of esophagojejunostomy leakage related to old age, obesity, malnutrition, neoadjuvant radiotherapy and chemotherapy, and the incidence rate was 1%-16.5%. The incidence of anastomotic leakage varies greatly, which suggests that effective preventive measures can reduce the probability of anastomotic leakage. In addition to the patient factors, the technique and experience of the operator are also important to reduce anastomotic leakage.
The safety of esophagojejunostomy depends on the integrity of the anastomosis, sufficient blood supply and satisfactory tension. Early tight mucosal anastomosis and the proliferation of mucosal epithelial cells can reduce the stimulation of digestive fluid to the anastomotic wound. However, there are some problems in the operation: 1. When esophagojejunostomy is completed with tubular stapler, it is the contraposition of the plasma muscular layer of the digestive tract; 2. Because of the different diameter of esophagojejunostomy and tissue hypertrophy, the internal mucosa layer of the anastomosis is often torn or the residual tissue is embedded in the anastomosis, which affects the healing of the anastomosis.
Double and a half layered esophagojejunal anastomosis was proposed to improve the safety of anastomosis. The procedure is as follows: after the end of esophagojejunostomy, 3/0 barbed suture or absorbable suture was used. First, the anastomotic site was sutured continuously for one circle, with the suture spacing of 3-4 mm and the width of 4-5 mm. Then, the continuous horizontal mattress type seromuscular layer varus suture was used to embed the anastomotic stoma for one circle, and the suture width was 5-8 mm above and below the anastomotic stoma. After the completion of esophagojejunostomy, the full-thickness reinforcement of the anastomosis and the embedding of the seromuscular layer can ensure the complete anastomosis of the mucosal layer of the anastomosis. The embedding of the seromuscular layer can also improve the anti-pressure and anti-tension of the anastomosis, and provide a guarantee for the primary healing of the anastomosis.
Conditions
- Surgery--Complications
Interventions
- PROCEDURE
-
double and a half layered esophagojejunal anastomosis
After the end of esophagojejunostomy, 3/0 barbed suture or absorbable suture was used. First, the anastomotic site was sutured continuously for one circle, with the suture spacing of 3-4 mm and the width of 4-5 mm. Then, the continuous horizontal mattress type seromuscular layer varus suture was used to embed the anastomotic stoma for one circle, and the suture width was 5\~8 mm above and below the anastomotic stoma. After the completion of esophagojejunostomy, the full-thickness reinforcement of the anastomosis and the embedding of the seromuscular layer can ensure the complete anastomosis of the mucosal layer of the anastomosis. The embedding of the seromuscular layer can also improve the anti-pressure and anti-tension of the anastomosis, and provide a guarantee for the primary healing of the anastomosis.
Sponsors & Collaborators
-
Luoyang Central Hospital
collaborator OTHER -
Nanyang Central Hospital
collaborator OTHER -
Henan Provincial People's Hospital
collaborator OTHER -
The First Affiliated Hospital of Zhengzhou University
collaborator OTHER -
Kaifeng Central Hospital
collaborator OTHER -
Henan Cancer Hospital
lead OTHER_GOV
Principal Investigators
-
Li Sen, Dr · Affiliated Cancer Hospital of Zhengzhou University
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-07-01
- Primary Completion
- 2024-06-01
- Completion
- 2024-06-01
Countries
- China
Study Locations
More Related Trials
-
Human Albumin and Anastomotic Leakage After Gastric Cancer Surgery
NCT04490668 ·Status: COMPLETED
-
Clinical Trial of Yiqi Wenyang Jiedu Prescription in the Prevention and Treatment of Postoperative Metastasis and Recurrence of Gastric Cancer
NCT05229809 ·Status: UNKNOWN ·Phase: PHASE4
-
A Clinical Prospective Study to Validate a Risk Scoring Model for the HMGC After Curative Surgery
NCT06023966 ·Status: COMPLETED
-
Portal Vein Occlusion is a Valuable Predictor for Postoperative Nausea and Vomiting
NCT05894408 ·Status: COMPLETED
-
Assessment of Graft Perfusion and Oxygenation for Improved Outcome in Esophageal Cancer Surgery
NCT03587532 ·Status: RECRUITING ·Phase: NA
-
Impact on Quality of Life in Patients Undergoing Total Gastrectomy or Proximal Gastrectomy for Adenocarcinoma of Esophagogastric Junction
NCT01697917 ·Status: UNKNOWN ·Phase: PHASE3
-
Longitudinal Assessment of Gut Hormone Secretion Following Upper Gastrointestinal Surgery for Cancer
NCT02385630 ·Status: COMPLETED ·Phase: NA
-
Influence of Early-feeding on Digestive Function of Patients After Esophageal Recontraction Surgery
NCT05892263 ·Status: UNKNOWN ·Phase: NA
-
Analysis of Influencing Factors of Preoperative Frailty in Elderly Patients With Gastric Cancer Based on the Health Ecology Theory
NCT04929587 ·Status: COMPLETED
-
Predictive Value of Preoperative Rectus and Diaphragm Muscle Thickness for Postoperative Complications in Gastrointestinal Cancer Surgery
NCT07098871 ·Status: COMPLETED
-
A Novel Nomogram to Predict the Postoperative Overall Survival in Gastrointestinal Cancer Patients
NCT05620537 ·Status: COMPLETED
-
Immunonutritional Supplement After Total Gastrectomy in Patients With Stage III Gastric Cancer
NCT05253716 ·Status: RECRUITING ·Phase: NA
-
Oral Supplementation of Glutamine on Gastric Cancer Patients After Gastrectomy
NCT06027242 ·Status: RECRUITING ·Phase: NA
-
Perioperative Nutrition in Upper Gastrointestinal (GI) Cancer Surgery
NCT00560846 ·Status: TERMINATED ·Phase: NA
-
Temporal Transformation Mechanism and Intervention Strategies of Frail-related Dietary Behaviors in Older Gastric Cancer Survivors
NCT07176455 ·Status: ENROLLING_BY_INVITATION
-
Randomized Clinical Trial: Nasoenteric Catheter or Jejunostomy
NCT01894490 ·Status: COMPLETED
-
Goal-directed Enteral Nutritional Perioperative Management
NCT06510543 ·Status: RECRUITING ·Phase: NA
-
Pancreatic Surgery and Risk Factors
NCT06585046 ·Status: COMPLETED
-
Enhanced Recovery After Surgery Program for Gastric Cancer: a Multi-center Study
NCT03121729 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Parenteral Nutrition Supplement on Esophagectomy Patients
NCT01669356 ·Status: COMPLETED ·Phase: NA
-
The Effect of Nutrition-optimized Prehabilitation on Perioperative Intervention in Primary Hepatocellular Carcinoma
NCT06549829 ·Status: RECRUITING ·Phase: NA
-
Early Oral Feeding for Patients After Pancreaticoduodenectomy
NCT05573399 ·Status: COMPLETED
-
Digestive Tract Reconstruction After Gastrectomy of Gastric Cancer With Type 2 Diabetes
NCT01637350 ·Status: UNKNOWN
-
Medium Calorie Parenteral Nutrition on Patients With Gastrointestinal Cancer Undergoing Surgery
NCT01700062 ·Status: COMPLETED ·Phase: PHASE4
-
PPIO-005 The Relationship Between Different Nutritional Pathways and Tumor Outcomes After Minimally Invasive Esophagectomy
NCT06192212 ·Status: COMPLETED